期刊文献+

口服普罗帕酮与胺碘酮联合电复律转复持续性房颤的随机对照试验 被引量:6

Comparison of Efficacy of Propafenone Versus Amiodarone with Electrical Cardioversion for Converting Persistent Atrial Fibrillation:A Clinical Randomized Controlled Trial
下载PDF
导出
摘要 目的比较普罗帕酮与胺碘酮联合电复律转复持续性心房颤动及维持窦性心律的疗效与安全性。方法将60例基础疾病治疗良好的持续性房颤患者随机分为两组,每组各30例。普罗帕酮组:普罗帕酮600mg顿服后观察6h,未转复者予电复律,并以最低有效量口服维持窦律;胺碘酮组:胺碘酮600mg分3次口服,连服7天,未转复者电复律,以最低有效量维持窦律。结果单纯药物复律,普罗帕酮组4例,胺电酮组3例,联合电复律两组分别转复25例和22例,两组早期有效率分别为90.0%和80.0%,晚期有效率分别为73.3%和70.0%,两组比较差异无统计学意义。住院时间普罗帕酮组短于胺碘酮组(P<0.001)。普罗帕酮组1例服药后出现一过性低血压,放弃复律,经对症治疗后好转;胺碘酮组4例服药后恶心、呕吐,未能坚持负荷量连服7天;但两组副反应发生率差异无统计学意义。结论普罗帕酮与胺碘酮联合电复律治疗持续心房颤动安全而有效,但普罗帕酮起效快,可相对减少患者的住院时间。 Objective To evaluate the effectiveness and safety of cardioversion and maintenance of sinus rhythm between two drugs (propafenone and amiodarone) in converting persistent atrial fibrillation. Methods Sixty patients with persistent atrial fibrillation were randomized into two groups, 30 in each group. One group underwent a loading dose of propafenone (600 mg) before electrical cardioversion and received propafenone maintenance therapy; the other group took amiodarone (200 mg three times per day for 7 days) before electrical cardioversion and sinus rhythm were maintained with amiodarone. Results Four patients in the propafenone group and 3 patients in the amiodarone group were converted to sinus rhythm. In the propafenone group, the maintenance rate of sinus rhythm was 90% at the end of 24-h follow-up, 73% at the end of 12.3 month follow-up, and 25 patients were converted. In the amiodarone group, the maintenance rate was 80% at the end of 24-h follow-up, 70% at the end of 12.4 month follow-up, and 22 patients were converted. There was no significant statistical difference between the two groups. But the average length of hospital stay was shorter in the propafenone group (P〈0.001). One patient in the propafenone group suffered transient hypotension, Their condition was improved after discontinuation of cardioversion and symptomatic treatment. Four patients in the amiodarone group developed nausea and vomiting after administration, and failed to complete the 7-day loading dose regimen. There was no significant statistical difference in adverse reactions between the two groups Conclusions Both propafenone and amiodarone with electrical cardioversion may convert persistent atrial fibrillation and maintain sinus rhythm effectively and safely. Compared with amiodarone, propafenone is preferred because it is associated with a shorter hospital stay.
出处 《中国循证医学杂志》 CSCD 2007年第3期165-168,共4页 Chinese Journal of Evidence-based Medicine
关键词 心房颤动 心脏复律-直流电 普罗帕酮 胺碘酮 随机对照试验 Atrial fibrillation Electrical cardioversion Propafenone Amiodarone Randomized controlled trial
  • 相关文献

参考文献10

  • 1Steinberg JS, Sadaniantz A, Kron J, et al. Analysis of cause-specific mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Circulation, 2004, 109(16):1973-1980.
  • 2胡大一,杨新春,刘彤.心房颤动的复律[J].中华心律失常学杂志,2000,4(1):43-45. 被引量:27
  • 3Curtis AB, Gersh B J, Corley SD, et al. Clinical factors that influence response to treatment strategies in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management(AFFIRM) study. Am HeartJ. 2005. 149(4): 645-49.
  • 4Koehiadakis GE, Igoumenidis NE, Parthenakis FI, et al. Amiodarone versus propafenone for conversion of chronic atrial fibrillation:results of a randomized, controlled study. J Am Coil Cardiol, 1999,33(4): 966-97 I.
  • 5Singh BN, Singh SN, Reda D J, et al. Amiodarone versus sotalol for atrial fibrillation. N Engl J Med, 2005, 352(I 8): 186 I-I 872.
  • 6Kosior DA, Opolski G, Wozakowska-Kaplon B, et al. Serial antiarrhythmic therapy: role of amiodarone in prevention of atrial fibrillation recurrence--a lesson from the HOT CAFE Polish Study.Cardiology, 2005, 104(I): 35--44.
  • 7Korantzopoulos P, Kolettis TM, Papathanasiou A, et al. Propafenone added to ibutilide increases conversion rates of persistent atrial fibrillation. Heart, 2006, 92(5): 631-634.
  • 8Bellandi F, Simonetti I, Leoncini M, et al. Long-term efficacy and safety of propafenone and sotalol for the maintenance of sinus rhythm after conversion of recurrent symptomatic atrial fibrillation.Am J Cardiol, 2001, 88(6): 640-645.
  • 9Kochiadakis GE, Marketou ME, Igoumenidis NE, et al.Amiodarone, sotalol, or propafenone in atrial fibrillation: which is preferred to maintain normal sinus rhythm? Pacing Clin Electrophysiol, 2000, 23(I I Pt 2): 1883-1887.
  • 10Goette A, Staack T, Rochen C, et al. Increased expression of extracellular signal regulation kinase and angiotensin converting enzyme in human atria during atrial fibrillation. JAm Coll Cardiol,2000, 35(6): 1669-16771.

二级参考文献10

  • 11,Levy S,Breithardt G,Compbell RW,etal.Atrial fibrillation:current knowledge and recommendations for management.Eur HeartJ,1998,19∶1294-1320.
  • 22,Ricard PH,Levy S,Trigano J,et al.Prospective assessment of the minimum energy neededfor external electrical cardioversion of atrial fibrillation.Am J Cardiol,1997,79∶815-816.
  • 33,Pritchett ELC.Management of atrial fibrillation.N Engl J Med,1992,326∶1264-1270.
  • 44,Falk RH,Knowlton AA,Bernard SA,et al.Digoxin for converting recent-onset atrialfibrillation to sinus rhythm.A randomized,double-blind trial.Ann Intern Med,1987,106∶503-506.
  • 55,Falk RH.Proarrhythmia in patients treated for atrial fibrillation or flutter.AnnIntern Med,1992,117∶141-150.
  • 66,Repique LJ,Shah SN,Marais GE.Atrial fibrillation 1992-Management strategies influx.Chest,1992,101∶1095-1103.
  • 77,Coume IP,Thomas O,Leenhardt A.Drug therapy for prevention of atrial fibrillation.Am JCardiol,1996,77(Suppl)∶3A-9A.
  • 88,Middlekauff HR,Wiener I,Stevenson WG.Low-dose amiodarone for atrial fibrillation. Am JCardiol,1993,72∶75F-81F.
  • 99,Karlson BW,Herlitz J,Edvardsson N,et al.Prophylactic treatment after electroconversionof atrial fibrillation.Clin Cardiol,1990,13∶279-286.
  • 1010,Ellenbogen KA,Stambler BS,Wood MA,et al.Efficacy of intravenous ibutilide for rapidtermination of atrial fibrillation and atrial flutter:a dose-response study. J Am CollCardiol,1996,28∶136-139. (

共引文献26

同被引文献42

引证文献6

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部